Period Ending | Jul 27, 2012 | Apr 27, 2012 | Jan 27, 2012 | Oct 28, 2011 |
---|
Total Revenue
|
4,008,000
|
4,297,000
|
3,706,000
|
4,235,000
| Cost of Revenue | 973,000 | 1,047,000 | 822,000 | 1,069,000 | |
Gross Profit
|
3,035,000
|
3,250,000
|
2,884,000
|
3,166,000
| |
|
Operating Expenses |
|
Research Development | 385,000 | 393,000 | 347,000 | 388,000 |
|
Selling General and Administrative | 1,444,000 | 1,510,000 | 1,632,000 | 1,356,000 |
|
Non Recurring | 5,000 | 190,000 | 3,000 | (12,000) |
|
Others | 80,000 | 80,000 | 81,000 | 88,000 |
|
|
|
Total Operating Expenses | 1,914,000 | 2,173,000 | 2,063,000 | 1,820,000 | | |
Operating Income or Loss
|
1,121,000
|
1,077,000
|
821,000
|
1,346,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 1,121,000 | 1,077,000 | 1,142,000 | 1,025,000 |
|
Interest Expense | 33,000 | 46,000 | 103,000 | (32,000) |
|
Income Before Tax | 1,088,000 | 1,031,000 | 1,039,000 | 1,057,000 |
|
Income Tax Expense | 224,000 | 143,000 | 204,000 | 184,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 864,000 | 888,000 | 835,000 | 873,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
| 103,000 | 99,000 | (2,000) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
864,000
|
991,000
|
934,000
|
871,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
864,000
|
991,000
|
934,000
|
871,000
|
|